FOR INVESTIGATING BIOCHEMICAL MARKERS OF PROGNOSIS OF MYOCARDIAL INFARCTION
Abstract
The mortality from cardiovascular disease in Russia remains high. The target of the real work was the research of new biochemical markers of сardiovascular diseases and their probable complications (an apolipoprotein of A1 (Apoa1), an apolipoprotein B (ApoB), relation ApoB/ApoA1) at residents of Altai region. It is shown that between men and women statistically significant distinctions are revealed on all analyzed markers of possible complications: contents ApoB, coefficient of ApoB/ApoA1 at men is higher, and the contents ApoA1 - is below, than at women.
About the Authors
R. I. Vorob’Ev
Regional Clinical Hospital of Emergency Medical Care
Russian Federation
Russian Federation
E. A. Sharlaeva
Altai State University
Russian Federation
Russian Federation
E. N. Vorob’Eva
Altai State Medical University of Minzdrav of Russia
Russian Federation
Russian Federation
G. G. Sokolova
Altai State University
Russian Federation
Russian Federation
References
1. Оганов Р.Г., Масленникова Г.Я. Проблемы сердечно-сосудистых заболеваний в Российской Федерации и возможности их решения // Рос. кардиол. журн. 2000. № 4. С. 7-11.
2. Sytkоwski P.A., D’Agostino R.B., Belanger A. еt al. Sex and time trends in cardiovascular disease incidence and mortality. The Framingham Heart Study 1950-1989 // Am. J. Epidemiol. 1996. N 143. P. 338-350.
3. Тожиев М.С., Шестов Д.Б., Воробьев А.М. и др. Распространенность сердечно-сосудистых заболеваний, факторы риска, эффективность многофакторной профилактики // Здравоохранение Российской Федерации. 2000. № 3. С. 6-9.
4. European guidelines on cardiovascular disease prevention in clinical practice // Eur. Heart J. 2003. Vol. 24. P. 1601-1610.
5. Шарлаева Е.А., Кузнецова К.А., Воробьева Е.Н., Казызаева А.С. Факторы риска заболеваний сердечно-сосудистой системы и оценка коронарного риска // Ломоносовские чтения на Алтае. Барнаул: Изд-во Алт. ун-та, 2013. Ч. VI. С. 55-66.
6. Rutten A., Abel T., Kannas L. et al. Self reported physical activity, public health, and perceived environment: results from a comparative European study // J. Epidemiol. Comm. Health. 2001. N 55. Р. 139-146.
7. Максимова Т.М., Какорина Е.П., Лушкина Н.П. и др. Оценка состояния здоровья населения по результатам пробной переписи населения 1997 г. // Пробл. социальной гигиены, здравоохранения и истории медицины. 1999. № 1. С. 12-17.
8. Добровольский А.Б., Титаева Е.В., Яровая Е.Б. и др. Д-димер, фибриноген и уровень артериального давления. Анализ популяции взрослого населения Томска // Атеротромбоз. 2014. № 2. С. 19-24.
9. Корякин А.М., Дадыка И.В., Епифанцева Н.Н. и др. С-реактивный белок и другие белки острой фазы воспаления у больных хроническим алкоголизмом // Сиб. мед. журн. 2007. Т. 22, № 2. С. 38-39.
10. Ridker P., Hennekens C., Buringf E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women // N. Engl. J. Med. 2000. Vol. 342. P. 836-843.
11. Mei X., Atkinson D. Lipid-free Apolipoprotein A-I Structure: Insights into HDL Formation and Atherosclerosis Development // Arch. Med. Res. 2015. Vol. 2. P. 188-190.
12. Gillard B., Alice Lin Hu-Yu, Massey J., Pownall H. Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells // Biochim. Biophys. Acta. 2009. Vol. 12. P. 1125-1132.
13. Chan D.C., Watts G.F. Apolipoproteins as markers and managers of coronary risk // An. Int. J. Med. 2006. Vol. 99. P. 161-171.
14. Dominiczak M.H., Caslake M.J. Apolipoproteins: metabolic role and clinical biochemistry applications // Annals of Cl. Biochem.: Int. J. Lab. Med. 2011. Vol. 48, N 6. Р. 498-515.
15. Walldius G., Jungner I. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy - a review of the evidence // J. Int. Med. 2006. Vol. 259, N 5. P. 493-519.
16. Chakraborty S., Cai Y., Tarr M.A. In vitro oxidative footprinting provides insight apolipoprotein B-100 structure in low-density lipoprotein // Proteomics. 2014. Vol. 14. P. 21-22.
17. Sung K.C., Ryu S., Wild S.H. et al. An increased high-density lipoprotein cholesterol/apolipoprotein A-I ratio is assocociated with increased cardiovascular and all-cause mortality // Heart. 2015. Vol. 101. P. 553-558.
18. Kaneva A.M., Potolitsyna N.N., Bojko E.R. et al. The apolipoprotein B/apolipoprotein A-I ratio as a potential marker of plasma atherogenicity // Dis Markers. 2015. Vol. 1. P. 13.
19. Yusuf S., Hawken S., Ounpuu S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study // Lancet. 2004. Vol. 364. Р. 937-952.
20. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) // JAMA. 2001. Vol. 285. P. 2486-2497.
Review
For citations:
Vorob’Ev R.I., Sharlaeva E.A., Vorob’Eva E.N., Sokolova G.G. FOR INVESTIGATING BIOCHEMICAL MARKERS OF PROGNOSIS OF MYOCARDIAL INFARCTION. Ateroscleroz. 2017;13(2):18-23. (In Russ.)
Views:
202
Email this article 